ConductScience.org, home

Paper39633459

Mechanisms underlying the compromised clinical efficacy of interferon in clearing HBV.

Lei Z and 10 others. Virol J, 2024. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Mechanisms underlying the compromised clinical efficacy of interferon in clearing HBV. Papers, record 39633459. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39633459

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mechanisms underlying the compromised clinical efficacy of interferon in clearing HBV.
PubMed
Journal
Virol J
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
2.67, provisional
iCite
Revised in PubMed
2025-04-25
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lei ZZhuoyan
2Wang LLuye
3Gao HHanlin
4Guo SShubian
5Kang XXinjian
6Yuan JJiajun
7Lv ZZiying
8Jiang YYuxin
9Yi JJinping
10Chen ZZhi
11Wang GGang

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antiviral AgentsMajor topic
Hepatitis B virusMajor topic
Hepatitis B, ChronicMajor topic
Interferon-alphaMajor topic
Humans
Hepatitis B
Interferons
Signal Transduction
Treatment Outcome
Virus Replication

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
82060304National Natural Science Foundation of ChinaPubMed
KXJ1723105Talent Introduction Project of Zhejiang Shuren UniversityPubMed
2024XZ013Zhejiang Shuren University Basic Scientific Research Special FundsPubMed

Source PubMed

Download CSV of grants

References137

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
18328741Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B. A meta-analysis.Ann Intern Med1993https://conductscience.org/library/papers/8328741PubMed
229679386Hepatitis B Virus Evasion From Cyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase Sensing in Human Hepatocytes.Hepatology2018https://conductscience.org/library/papers/29679386PubMed
323332086A multicenter survey of re-treatment with pegylated interferon plus ribavirin combination therapy for patients with chronic hepatitis C in Japan.Hepatol Res2013https://conductscience.org/library/papers/23332086PubMed
421478870A diverse range of gene products are effectors of the type I interferon antiviral response.Nature2011https://conductscience.org/library/papers/21478870PubMed
524604126Recent insights into hepatitis B virus-host interactions.J Med Virol2014https://conductscience.org/library/papers/24604126PubMed
627003258HBsAg blocks TYPE I IFN induced up-regulation of A3G through inhibition of STAT3.Biochem Biophys Res Commun2016https://conductscience.org/library/papers/27003258PubMed
729456079Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B.J Formos Med Assoc2018https://conductscience.org/library/papers/29456079PubMed
821334391The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.J Hepatol2011https://conductscience.org/library/papers/21334391PubMed
933845868Potential capacity of interferon-α to eliminate covalently closed circular DNA (cccDNA) in hepatocytes infected with hepatitis B virus.Gut Pathog2021https://conductscience.org/library/papers/33845868PubMed
102732449Interferon antibodies in patients with chronic HBV infection treated with recombinant interferon.J Hepatol1989https://conductscience.org/library/papers/2732449PubMed
1128139375Transcriptional Regulation of Antiviral Interferon-Stimulated Genes.Trends Microbiol2017https://conductscience.org/library/papers/28139375PubMed
1210756029Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice.J Virol2000https://conductscience.org/library/papers/10756029PubMed
1326566064AASLD guidelines for treatment of chronic hepatitis B.Hepatology2016https://conductscience.org/library/papers/26566064PubMed
1415031497Inhibition of hepatitis B virus replication by APOBEC3G.Science2004https://conductscience.org/library/papers/15031497PubMed
1529715359Chronic Hepatitis B Infection: A Review.JAMA2018https://conductscience.org/library/papers/29715359PubMed
1626134841Hepadnavirus Genome Replication and Persistence.Cold Spring Harb Perspect Med2015https://conductscience.org/library/papers/26134841PubMed
1728432378Advances in anti-viral immune defence: revealing the importance of the IFN JAK/STAT pathway.Cell Mol Life Sci2017https://conductscience.org/library/papers/28432378PubMed
1827283515The APOBEC Protein Family: United by Structure, Divergent in Function.Trends Biochem Sci2016https://conductscience.org/library/papers/27283515PubMed
1938336347Major HBV splice variant encoding a novel protein important for infection.J Hepatol2024https://conductscience.org/library/papers/38336347PubMed
201060140Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles.Proc Natl Acad Sci U S A1975https://conductscience.org/library/papers/1060140PubMed

See all 137 referencesDownload CSV of references

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42828128PYHIN proteins: guardians or contributors to hepatitis B virus pathogenesis?Front Immunol2026https://conductscience.org/library/papers/42828128PubMed
42510927Liver Macrophages in the Pathogenesis of Viral Hepatitis.Curr Issues Mol Biol2026https://conductscience.org/library/papers/42510927PubMed
42503914[Advancement in the role of exosomes for hepatitis B virus infection diagnosis and treatment: mechanisms and clinical applications].Zhonghua Gan Zang Bing Za Zhi2026https://conductscience.org/library/papers/42503914PubMed
42246003Sustained HBsAg clearance induced by pegylated interferon α-2b in HBeAg-negative patients with low baseline HBsAg.Front Cell Infect Microbiol2026https://conductscience.org/library/papers/42246003PubMed
42209159[Expert recommendations on the management of adverse reactions in pegylated interferon alpha therapy for chronic hepatitis B].Zhonghua Gan Zang Bing Za Zhi2026https://conductscience.org/library/papers/42209159PubMed
42075882Repurposing Product Nkabinde for Hepatitis B Virus Therapy: A Network Pharmacology and Molecular Docking Investigation.Pharmaceuticals (Basel)2026https://conductscience.org/library/papers/42075882PubMed
42021267Predictive value and mechanism of LINC00665 for liver dysfunction in pregnant women with hepatitis B during early pregnancy.Virol J2026https://conductscience.org/library/papers/42021267PubMed
42016067Precise delivery of medical gases by engineered nanomedicine for enhanced liver fibrosis therapy.Mater Today Bio2026https://conductscience.org/library/papers/42016067PubMed
41924278Interferon therapy for chronic hepatitis B in children: an immunological perspective.Front Immunol2026https://conductscience.org/library/papers/41924278PubMed
41514917Hepatic Macrophages in Chronic Hepatitis B: Balancing Immunity and Pathology.Biology (Basel)2025https://conductscience.org/library/papers/41514917PubMed
41179730Hepatitis B functional cure: Current and future perspective.World J Hepatol2025https://conductscience.org/library/papers/41179730PubMed
41014398Do the therapeutic vaccines hold hope for the treatment of hepatitis B?Hepatol Int2025https://conductscience.org/library/papers/41014398PubMed
40772275Genetic association between STAT4 and primary Sjögren's syndrome in Han Chinese women.Front Genet2025https://conductscience.org/library/papers/40772275PubMed
40771315Exosome in HBV infection: current concepts and future perspectives.Front Cell Infect Microbiol2025https://conductscience.org/library/papers/40771315PubMed
40655152Virus-host interaction mechanisms in interferon therapy for hepatitis B virus infection: recent advances.Front Immunol2025https://conductscience.org/library/papers/40655152PubMed
40408617Bioinformatics and system biology approach to discover the common pathogenetic processes between COVID-19 and chronic hepatitis B.PLoS One2025https://conductscience.org/library/papers/40408617PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IFNA13439PubTator's text mininghttps://conductscience.org/library/genes/3439NCBI Gene
KRT88P85348PubTator's text mininghttps://conductscience.org/library/genes/85348NCBI Gene
STAT16772PubTator's text mininghttps://conductscience.org/library/genes/6772NCBI Gene
STAT36774PubTator's text mininghttps://conductscience.org/library/genes/6774NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39633459

GET https://conductscience.org/api/papers/v1/39633459/references?page=2